CELSUNAX

This brand name is authorized in Estonia, Croatia, Ireland, Lithuania, Poland

Active ingredients

The drug CELSUNAX contains one active pharmaceutical ingredient (API):

1 Ioflupane ¹²³I UNII 3MM99T8R5Q - IOFLUPANE I-123

Ioflupane ¹²³I is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Read about Ioflupane ¹²³I

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CELSUNAX Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09AB03	Iodine ioflupane (123I)	V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AB Iodine (123I) compounds
Discover more medicines within V09AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1852253, 1852264
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092836, 1092837
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100455362